Ethical and Clinical Considerations in the Use of Hydroxyurea in Pregnant Women with Sickle Cell Disease

被引：2

作者：

Desai, Gayatri ^{[1
]}

Dave, Kapilkumar ^{[1
]}

Devare, Sumeet ^{[1
]}

Desai, Shrey ^{[1
]}

机构：

[1] SEWA Rural, Jhagadia, India

来源：

HEMOGLOBIN | 2024年 / 48卷 / 01期

关键词：

Sickle cell disease; hydroxyurea; pregnancy; OUTCOMES;

D O I：

10.1080/03630269.2024.2310283

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：66 / 68

页数：3

共 28 条

[1]

Amortegui A J, 1983, Prog Clin Biol Res, V140, P13

[2]

[Anonymous], FREQUENTLY ASKED QUE

[3]

[Anonymous], 2019, RES C FDA APPROVES H

[4]

[Anonymous], BRIT J HAEMATOLOGY W, DOI [10.1111/bjh.17671, DOI 10.1111/BJH.17671]

[5]

[Anonymous], 2004, Managing Archaeological Archives. A Policy and Guidance for the National Trust Archaeology Section, P1

[6] Excess Risk of Maternal Death from Sickle Cell Disease in Jamaica: 1998-2007 [J].

Asnani, Monika R. ;

McCaw-Binns, Affette M. ;

Reid, Marvin E. .

PLOS ONE, 2011, 6 (10)

[7] Exposure to Hydroxyurea and Pregnancy Outcomes in Patients With Sickle Cell Anemia [J].

Ballas, Samir K. ;

McCarthy, William F. ;

Guo, Nan ;

DeCastro, Laura ;

Bellevue, Rita ;

Barton, Bruce A. ;

Waclawiw, Myron A. .

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2009, 101 (10) :1046-1051

[8] VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J].

Bates, Shannon M. ;

Greer, Ian A. ;

Middeldorp, Saskia ;

Veenstra, David L. ;

Prabulos, Anne-Marie ;

Vandvik, Per Olav .

CHEST, 2012, 141 (02) :E691S-E736S

[9]

Boafor TK., 2017, OBSTET ANESTH DIG, V37, P9, DOI [10.1097/01.aoa.0000511999.06517.f5, DOI 10.1097/01.AOA.0000511999.06517.F5]

[10] Dose-response relationships of rat fetal skeleton variations: Relevance for risk assessment [J].

Chahoud, Ibrahim ;

Paurngartten, Francisco J. R. .

ENVIRONMENTAL RESEARCH, 2009, 109 (07) :922-929

← 1 2 3 →